Cita APA

Vega, F. M., Colmenero-Repiso, A., Gómez-Muñoz, M. A., Rodríguez-Prieto, I., Aguilar-Morante, D., Ramírez, G., . . . Pardal, R. (2020). Response to “High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma”. EBioMedicine.

Chicago Style Citation

Vega, Francisco M., Ana Colmenero-Repiso, María A. Gómez-Muñoz, Ismael Rodríguez-Prieto, Diana Aguilar-Morante, Gema Ramírez, Catalina Márquez, Rosa Cabello, i Ricardo Pardal. "Response to “High CD44 Expression Is Not a Prognosis Marker in Patients With High-risk Neuroblastoma”." EBioMedicine 2020.

Cita MLA

Vega, Francisco M., et al. "Response to “High CD44 Expression Is Not a Prognosis Marker in Patients With High-risk Neuroblastoma”." EBioMedicine 2020.